
Wong Lab Publications
Learn more about research being performed in the Wong Lab by reading our latest publications.
Recent Publications
TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy
Cancer research. 2025 Aug 29;
Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945
NPJ precision oncology. 2025 Aug 20; 9:294
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
Prostate cancer & prostatic diseases. 2025 Jun ; 28:363-369
Surgical Resection of Murine PDAC Alters Hepatic Metastases and Immune Microenvironment
Pancreas. 2025 May 23;
In Vivo Efficacy of a Macrocyclic Peptoid-Peptide Hybrid That Selectively Modulates the Beta-Catenin/TCF Interaction to Inhibit Prostate Cancer
Prostate. 2025 May ; 85:646-658
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C
Cancer discovery. 2025 Mar 03; 15:578-594
Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data
Nature biomedical engineering. 2025 Mar ; 9:405-419
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models
Journal of clinical investigation. 2024 Dec 24; 135: